Back to company

MAXIPHARMA A/S: Financial statements 2012

CVR: 87375617

MAXIPHARMA A/S (CVR 87375617) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK 1,517,078 and a net result of DKK 740,393. Equity amounted to DKK 2,298,478. The solvency ratio was 61.8%. The company had 2 employees in the financial year.

Gross Profit
1,517,078 kr.
Profit/Loss
740,393 kr.
Equity
2,298,478 kr.
Total Assets
3,721,441 kr.
Employees
2

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is MAXIPHARMA A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2012

Auditor steps down at MAXIPHARMA A/SDec 31, 2012

As of December 31, 2012, ALBERT PEDERSEN. STATSAUTORISEREDEREVISORER I/S has stepped down as auditor of MAXIPHARMA A/S.

About MAXIPHARMA A/S

MAXIPHARMA A/S is a Danish company of the type Aktieselskab based in Højbjerg, founded in 1979. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Jesper Bjerre Jensen. The company is owned by AKTIESELSKABET SGJ. The company has 2 employees. In 2025, the company reported a gross profit of DKK 1,791,625 and a net result of DKK 434,996 compared with DKK 411,322 the year before. Equity amounted to DKK 4,204,696.